Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AARROWHEAD PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

ARROWHEAD PHARMACEUTICALS, INC.

$61.62Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $75.25M. Net result −$178.92M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $75.25M. Running result $75.25M. Revenue: $75.25M.
  • Cost of revenue: $0. Running result $75.25M.
  • Gross profit: $75.25M. Running result $75.25M.
  • Research and development: −$198.22M. Running result −$122.97M.
  • Selling, general and administrative: −$47.12M. Running result −$170.09M.
  • Operating income: −$170.09M. Running result −$170.09M.
  • Other expense: −$8.81M. Running result −$178.91M.
  • Pre-tax loss: −$178.91M. Running result −$178.91M.
  • Income tax expense: −$11K. Running result −$178.92M.
  • Net loss: −$178.92M. Running result −$178.92M.